Medison is a global pharma company focused on providing access to highly innovative therapies to patients in international markets. Endocrinology focused products: JUXTAPID (lomitapide), approved by Health Canada to treat adults with homozygous familial hypercholesterolemia and a pipeline product for leptin deficiency in lipodystrophy patients.